Most of this guide's warnings are about wasted money. A setting left on, a keyword too broad, a bid too high. Those mistakes cost a practice some budget, and they can be fixed next week.
This chapter is about a different kind of mistake. A handful of service lines run into Google policies strict enough that a single ad can get the practice's entire Google Ads account suspended. Not the campaign. Not the service line. The account, with every other line in it.
For a practice built on primary care and physical therapy, most of this never comes up. For a practice that has added pain management, medical weight loss, a men's health clinic or regenerative injections, it's the most important chapter in the guide.
Most Specialties Live With Google's Health Rules. Four Kinds of Service Line Hit a Wall.
Every healthcare advertiser deals with Google's health rules: the personalized advertising limits from Chapter 10, the privacy care from Chapter 1. Those shape how a campaign is built. They don't end it.
Four kinds of service line are different, because each runs into its own policy with much harder edges:
- Pain management runs into Google's policy on prescription opioid painkillers.
- Medical weight loss runs into Google's restricted drug terms, because the medications behind it are prescription drugs, and into its rules on unrealistic weight loss claims.
- Men's health runs into the same drug terms and into Google's sexual health and wellness policy.
- Regenerative injections, such as PRP or stem cell treatments, run into Google's policy on speculative and experimental treatments. That one reaches orthopedics, pain management, dermatology and men's health alike.
A multi-specialty practice may have one of these lines or several. Each needs to be handled as its own risk, with the rest of the account protected from it.
One Mention of Opioids Can Suspend the Whole Account Without Warning
The strictest rule belongs to pain management. Google doesn't allow ads for prescription opioid painkillers, with narrow exceptions for medication-assisted treatment, public health campaigns and certified addiction treatment providers. For everyone else, Google's wording leaves no room: advertisers without those qualifications "are prohibited from referring to opioid painkillers in their ads whatsoever."
The consequence is what makes this policy different from almost everything else in Google Ads. Google says violations "are considered egregious," a category it reserves for violations so serious they're unlawful or pose significant harm to users, and that accounts are suspended upon detection "without prior warning." There's no disapproved ad to fix first. The account simply stops.
For a pain practice, the practical rule is to never name an opioid anywhere an ad can reach it, even to say the practice avoids them. A line like "opioid-free pain relief" still refers to opioids, and it's exactly the kind of edge case a practice shouldn't test with its whole account. Market what the practice actually does instead: the injections, the nerve blocks, radiofrequency ablation, physical therapy and the evaluation that decides between them. Those are the searches that book pain patients anyway. On the keyword side, add opioid drug names to the pain campaigns' negative keyword lists, so broad match in Exploration never pairs an ad with a search for a painkiller.
GLP-1 and Testosterone Names Can Appear in an Ad but Not in a Keyword
Medical weight loss and men's health clinics both build their services around prescription drugs: GLP-1 medications for weight loss, testosterone for low-T treatment. Google's restricted drug terms policy covers those names, and in the United States it splits them three ways.
An in-person clinic may put the drug's name in its ad copy and on its page with no certification at all, as long as it's promoting a lawful service. Keyword targeting is different. Bidding on the name is where the door closes. That takes a certification, and the certification types Google lists are for businesses like online pharmacies, telehealth providers and drug makers. We found none that fits a clinic that sees patients in person. So a weight loss practice can say which medications it prescribes in its ads, but it can't bid on the drug names themselves.
There's a third effect that's easy to miss. Google's personalized advertising rules treat prescription drug content as a sensitive category, so a landing page that names the medication loses the same audience options Chapter 10 described. And weight loss ads carry one more rule: Google's unreliable claims policy prohibits claims of unrealistic weight loss in a specific time frame or with little effort. "Drop four sizes in a month" is the kind of line that policy was written for.
One more drug belongs on this list for multi-specialty practices with a psychiatry line. Ketamine and esketamine treatments for depression aren't named on the Google policy pages we checked, but they're prescription drugs, so the same restricted drug terms rules apply to them: name them in an ad or on a page if local law allows, but don't bid on them as keywords.
The workable approach is to target the searches about the visit, not the drug: "medical weight loss clinic near me," "weight loss doctor," "low testosterone doctor." Those searches come from people looking for a provider, which is who the practice wants anyway.
PRP and Stem Cell Injections Can't Be Advertised at All
Regenerative treatments are the rule that catches practices by surprise, because they're offered in so many specialties. Regenerative medicine sits on Google's banned list by name. Its policy on speculative and experimental treatments spells out stem cells, other cell-based and gene therapies, and platelet-rich plasma, the injections most practices simply call PRP.
That reaches orthopedic practices offering stem cell knee injections, pain practices offering regenerative injections, dermatology and hair restoration practices offering PRP, and men's health clinics offering PRP treatments. Google allows an exception for FDA licensed or approved cell and gene therapies promoted by the entities that hold that approval, and for content that's purely educational. A practice advertising its own PRP injections fits neither. An orthopedic line can still advertise the knee injections Google does allow, such as a cortisone injection, as long as regenerative options stay off the ad and the page it points to.
This policy isn't enforced the same way as opioids. Google says violations get a warning at least 7 days before any suspension of the account. That's a window to fix the problem, not permission to run the ads. The simplest fix is to leave regenerative treatments out of every ad, and keep landing pages for those services out of the account entirely.
A Men's Health Clinic Advertises the Visit, Not the Pill
Men's health has one more policy of its own. Google's sexual health and wellness policy allows ads for prescription erectile dysfunction drugs only in limited cases, on the Display Network and YouTube, and only for three kinds of advertiser: pharmaceutical manufacturers, online pharmacies and telemedicine providers, who must apply first. An in-person men's health clinic isn't one of them.
So the ads sell the appointment. A consultation, an evaluation for low testosterone, a men's health checkup: those are services a clinic provides, and they're what the ad and the landing page should be about. The medications can be discussed after the patient walks in. The same goes for the PRP treatments some men's health clinics offer, which fall under the experimental treatment rule above and stay out of the ads entirely.
The Risky Line Gets Its Own Campaign, Clean Pages and No AI-Written Copy
Chapter 14 gave every service line its own campaigns. For these lines, that separation does real work. It keeps their ads, keywords and landing pages in one place, where they can be reviewed on their own, and it keeps their rules from bleeding into the rest of the account.
But a suspension happens at the account level, so the protection has to come before anything goes live. Before a pain, weight loss, men's health or regenerative line launches, read every ad and every landing page it points to, line by line, against the policies above. Check the pages a patient can reach from those landing pages, too, since Google reviews the destination, not just the ad.
Then keep automation away from these lines. Chapter 13 explained that AI Max's text customization writes ad text from anything on the practice's website. A blog post that mentions opioids, a service page that names a GLP-1 drug, a testimonial about PRP: any of those can become an ad line the practice never wrote. For these service lines, leave AI Max and automatically created assets off, and keep the ads to lines a person has checked.
Finally, know where certification actually applies. LegitScript certification, which Google uses for some healthcare categories, covers telemedicine providers that prescribe online and addiction treatment services. If the practice adds either, it needs LegitScript certification, and then Google's own certification, before advertising them. For the in-person services in this chapter, the answer isn't certification. It's writing ads and pages that stay inside the rules.
If the worst happens and the account is suspended, Google's policy pages point to one path: if you believe there's been an error, appeal the decision from inside the Google Ads account. Fix the ad or page first, so the appeal describes a problem that's already gone. Don't open a new account to keep advertising while the old one is suspended. Google treats that as trying to get around its enforcement, and it turns one problem into a much bigger one.
Our specialty guides cover these rules in their own fields. The med spa guide covers the Google Ads rules on semaglutide. The dermatology guide covers why Botox can go in an ad but bidding on it takes a certification.
Next: The Question Patients Ask Before They Book
One question comes before almost every booking, and an ad can answer it before the patient asks: do you take my insurance? Chapter 16 covers insurance, Medicare and self-pay, and how to answer that question in the ad itself.
Catch up on Chapter 14 on one campaign per service line, or see every chapter on the guide home for Google Ads for Healthcare. Before a restricted line's ads run under our Google Ads management, every ad and landing page is checked against these policies.
